How do I buy AC IMMUNE SA (ACIU) stock?

Buying AC IMMUNE SA (ACIU) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "ACIU", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy ACIU by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if ACIU is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

AC IMMUNE SA (ACIU) Stock

Q: What is the minimum investment for ACIU on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in AC IMMUNE SA from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NMQ · ACIU

Trade ACIU

Key stats

Market cap: $207.80M
Price / Earnings ratio: -4.0x
EPS (TTM): -$0.53
Volume: Loading
52-week high: $3.90
52-week low: $2.02

Source: third-party data provider, as of November 5, 2026

Compare with ACIU

Technical indicators

RSI 14: 44.65
MACD 12/26/9: -0.10
EMA 9 of MACD: -0.09
MACD histogram: -0.02
SMA 50: $2.57; Price below SMA 50
EMA 50: $2.47; Price below EMA 50
SMA 200: $2.71; Price below SMA 200
EMA 200: $2.74; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of November 4, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 1 analyst rating

Strong Sell0

Sell0

Hold0

Buy1

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2025

5M4M2M0

Debt & Balance Sheet

Total assets

Total liabilities

2025

185M122M61M0

Revenue to Profit

2025

$4.5M

Revenue

$0.0

Cost of revenue

$3.6M

Gross profit

$0.0

Operating expenses

$-70.4M

Net income

Earnings

EPS forecast

Actual EPS

Q2FY26

The market has no earnings per share expectations for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About AC IMMUNE SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

SectorHealthcare

IndustryBiotechnology

Employees90

CEODr. Martin Zugel M.D., Ph.D.

IPO DateSep 23, 2016

HeadquartersLausanne, Switzerland

Key Executives

Name	Title	Year Born
Dr. Martin Zugel M.D., Ph.D.	Interim CEO & Chairman of the Board	1963
Mr. Christopher Roberts	CFO & VP of Finance	1990
Mr. Piergiorgio Donati	Chief Operating Officer	1971
Dr. Gary Anthony Waanders Ph.D.	Senior VP of Investor Relations & Corporate Communications	1964
Dr. Matthias Maurer Ph.D.	Senior VP & General Counsel	1982
Dr. Oliver Sol M.D.	VP & Head of Clinical Development	1968
Dr. Julien Rongere Ph.D.	Senior Vice President of Regulatory Affairs & Quality Assurance	1978
Mr. Mark Danton	Executive Vice President of Information Systems & Artificial Intelligence	1964
Dr. Günther Staffler Ph.D.	Executive Vice President of Development	1969
Dr. Francesca Capotosti	Senior Vice President of Research	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-30.4	+1.4
2022	-14.3	-14.0	-3.1	-14.6	-8.7	+16.1	+4.5	-5.9	+7.1	-11.1	-15.0	-19.0
2023	+12.2	-8.0	-2.1	-14.2	+9.5	+28.7	+3.1	+11.3	-15.7	+5.6	+12.2	+47.1
2024	-31.6	+13.8	-23.1	-9.2	+86.0	-17.4	+2.8	-15.4	+23.5	-24.3	+13.3	-15.9
2025	-3.5	-5.9	-22.1	-3.9	+2.4	+23.0	+9.1	-3.8	+30.8	+11.2	-6.0	+14.6
2026	-5.1	-10.4	-4.5	+8.6	-10.7	-3.3	-8.0	+18.9	-2.2	-21.0	+11.2

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

Agios Pharmaceuticals, Inc.

FAQ

Buying AC IMMUNE SA (ACIU) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "ACIU", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy ACIU by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in AC IMMUNE SA from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, AC IMMUNE SA (ACIU) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track ACIU's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

AC IMMUNE SA (ACIU) Stock

Key stats

Compare with ACIU

Recent news

Best Momentum Stock to Buy for September 30th

Best Momentum Stock to Buy for September 30th

AC Immune Parkinson's Vaccine Study Meets Safety, Immunogenicity Goals

AC Immune Parkinson's Vaccine Study Meets Safety, Immunogenicity Goals

ACIU Stock Heads For Best Day In Over 10 Months On FDA Fast Track Nod For Parkinson’s Disease Therapy – Retail Sees ‘Breakout Soon’

ACIU Stock Heads For Best Day In Over 10 Months On FDA Fast Track Nod For Parkinson’s Disease Therapy – Retail Sees ‘Breakout Soon’

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Best Momentum Stock to Buy for September 30th

Best Momentum Stock to Buy for September 30th

AC Immune Parkinson's Vaccine Study Meets Safety, Immunogenicity Goals

AC Immune Parkinson's Vaccine Study Meets Safety, Immunogenicity Goals

ACIU Stock Heads For Best Day In Over 10 Months On FDA Fast Track Nod For Parkinson’s Disease Therapy – Retail Sees ‘Breakout Soon’

ACIU Stock Heads For Best Day In Over 10 Months On FDA Fast Track Nod For Parkinson’s Disease Therapy – Retail Sees ‘Breakout Soon’

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

AC Immune (ACIU) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

AC Immune (ACIU) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

AC Immune (ACIU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

AC Immune (ACIU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

AC Immune (ACIU) Reports Q1 Loss, Tops Revenue Estimates

AC Immune (ACIU) Reports Q1 Loss, Tops Revenue Estimates

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know

Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?

Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?

Why AC Immune Stock Zoomed Almost 15% Higher Today

Why AC Immune Stock Zoomed Almost 15% Higher Today

About AC IMMUNE SA

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade